How Much Is Lanceart AB Worth?
Lanceart AB - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
828,843 kr
How This Is Valued
- Capitalised Earnings (EV/EBITDA)
- 828,843 kr
- Revenue Multiple
- 128,200 kr
- Range
- 650,435 kr–1,093,435 kr
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- B+
- Altman Z″Indicates financial-distress risk. A higher score is stronger. Learn More ↗ Opens in a New Tab
- 27.04
- Risks
- Insufficient Data
Scope & Evidence
- Company
- Lanceart AB
- Registration
- SE · 5568508708
- Covers
- Not stated in the filing
- Filings Used
- 4 · FY 2025, 2024, 2023, 2022
Valuation by Method
Capitalised Earnings (EV/EBITDA)
828.8k kr
Revenue Multiple
128.2k kr
0 kr
250k kr
500k kr
750k kr
1m kr
Industry: NACE 86 · 1 Europe industry cohort
Methodology & Assumptions
- Maintainable EBITDA
- 81,047 kr
- Industry EV / EBITDA
- 10.2×
- EV / EBITDA Multiple
- 10.2×
- Industry Revenue Multiple
- 1.40×
- Revenue Multiple
- 1.40×
- Enterprise Value
- 828,843 kr
- Value Before Discount
- 828,843 kr
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 17.10×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.06×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 94.2%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- ≥ 100.00×
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 71.7%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 22.7%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- 21.4%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- -
Asset Distribution
Fixed AssetsCashReceivablesOther Assets
Liability Maturity
Short-Term
3-Year Revenue Scenarios
200k kr
150k kr
100k kr
50k kr
0 kr
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- Lideta Mälardalen AB
- 410,101,009 kr
- Doktor 24 Healthcare AB
- 318,065,000 kr
- MA Medical AB
- 1,737,403 kr
- Lanceart AB ★
- 150,700 kr
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
165k kr
110k kr
55k kr
0 kr
-55k kr
2022202320242025
RevenueEBITDANet Profit
Versus Industry Median
600k kr
450k kr
300k kr
150k kr
0 kr
RevenueNet Profit
This CompanyIndustry Median